|
A case report of successful treatment following rice pill poisoning in a 60-year-old woman
|
Masih Shakeri  , Heshmatollah Shakeri , Zhila Rahmanian , Farideh Mogharab , Navid Kalani * , Shahram Shafa , Hossein Ali Rostami Pourfard |
|
|
|
Abstract: (1128 Views) |
Introduction: Acute poisoning is a major global problem and one of the leading causes of death. Aluminum phosphide (ALP), which is known as rice pellet in Iran, has a very high lethality. ALP poisoning has no specific antidote. However, previous studies have suggested some treatments such as gastric lavage with sodium bicarbonate and charcoal consumption. The present study reported a case of successful treatment of rice pill poisoning.
Introduction of the patient: The patient, a 60-year-old woman, referred to the emergency room of Motahhari Hospital due to abdominal pain. Clinical examination of the patient revealed that the patient had experienced abdominal pain due to vomiting without hematuria due to taking rice pills. The patient was fully conscious at the time of admission and vital signs BP 110/70 _RR 20_PR 86_O2SAT 92 were recorded. The patient was first NPO and a nasopharyngeal tube was inserted. 150 cc of normal saline with olive oil was given to the patient via NG. Pantoprazole_vitamin C ampoule, indasterone ampoule, 8 units of regular insulin with 50% dextrose water and one gram of ceftriaxone and calcium gluconate were injected into the patient.
Conclusion: In patients with rice pill poisoning due to the lack of specific antibodies in the treatment of this group of patients need rapid diagnosis and supportive therapies. The results of this study showed that rapid emptying and dilution of gastric contents, administration of olive oil, bicarbonate, stabilization of cell membrane potential and other therapeutic measures can save the lives of patients. |
|
| Keywords: Treatment, Poisoning, Rice Pills. |
|
|
Full-Text [PDF 594 kb]
(114 Downloads)
|
Type of Study: Research |
Subject:
Dakheli
Received: 2021/11/6 | Revised: 2021/12/12 | Accepted: 2021/12/3
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
